AGP Executive Report
Last update: 23 minutes agoNewborn Pain Care in B.C.: Kinetix Medicine says it has bought the first Neurolyser XR system for the Vancouver area, with first treatments planned for Aug. 26—aimed at incision-free ultrasound treatment for chronic lumbar facet joint pain. Skin Treatment Update: Health Canada approved PrZORYVE (roflumilast) cream 0.05% for children ages 2–5 with mild to moderate atopic dermatitis, positioning it as a once-daily, steroid-free option. Neuroimaging Tech Push: Cubresa received FDA 510(k) clearance for its BrainPET scanner, designed to retrofit into existing Siemens MR/PET setups to expand access to high-resolution brain imaging. Public Health & Safety: B.C. vets warn of a surge in bat encounters after a rabies-positive test, with health officials recommending boosters for a person exposed. Ebola Response: WHO says Congo will receive 70,000 doses of the Ervebo Ebola vaccine, including doses for a Phase 3 trial and frontline protection for workers. Legal Aid Pressure (Manitoba): The Canadian Civil Liberties Association filed a Charter challenge over “extreme” underfunding of criminal legal aid in Manitoba. Wildfire Smoke Alert (B.C.): Southern Interior residents faced worsened air quality as wildfire smoke thickened, with officials urging people to limit strenuous outdoor activity.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
